89 related articles for article (PubMed ID: 7000169)
1. A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies.
Poller L; Thomson JM; Coope J
Br J Obstet Gynaecol; 1980 Aug; 87(8):718-25. PubMed ID: 7000169
[TBL] [Abstract][Full Text] [Related]
2. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women.
Thomson J; Oswald I
Br Med J; 1977 Nov; 2(6098):1317-9. PubMed ID: 338104
[TBL] [Abstract][Full Text] [Related]
3. Is oestrogen therapy effective in the treatment of menopausal depression?
Coope J
J R Coll Gen Pract; 1981 Mar; 31(224):134-40. PubMed ID: 6268783
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
[TBL] [Abstract][Full Text] [Related]
5. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
Isaacs AJ; Havard CW
Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric.
Aylward M
Postgrad Med J; 1978; 54 Suppl 2():31-7. PubMed ID: 740578
[TBL] [Abstract][Full Text] [Related]
7. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
Towobola OA; Crilly RC; Oakey RE
Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
[TBL] [Abstract][Full Text] [Related]
8. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
Lagrelius A; Lunell NO; Blombäck M
Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
[TBL] [Abstract][Full Text] [Related]
9. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.
Wilson PD; Faragher B; Butler B; Bu'Lock D; Robinson EL; Brown AD
Br J Obstet Gynaecol; 1987 Jun; 94(6):568-74. PubMed ID: 3113475
[TBL] [Abstract][Full Text] [Related]
10. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Varma TR
Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083
[TBL] [Abstract][Full Text] [Related]
11. Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory.
Hackman BW; Galbraith D
Curr Med Res Opin; 1976; 4(4):303-6. PubMed ID: 791587
[TBL] [Abstract][Full Text] [Related]
12. Effect of piperazine oestrone sulphate on serum lipids and lipoproteins in menopausal women.
Isaacs AJ; Havard CW
Acta Endocrinol (Copenh); 1977 May; 85(1):143-50. PubMed ID: 577072
[TBL] [Abstract][Full Text] [Related]
13. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
Alexandersen P; Byrjalsen I; Christiansen C
BJOG; 2000 Mar; 107(3):356-64. PubMed ID: 10740332
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
15. The effect of type and dose of oestrogen on the blood pressure of post-menopausal women.
Wren BG; Routledge AD
Maturitas; 1983 Aug; 5(2):135-42. PubMed ID: 6314097
[TBL] [Abstract][Full Text] [Related]
16. Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting.
Coope J; Thomson JM; Poller L
Br Med J; 1975 Oct; 4(5989):139-43. PubMed ID: 172181
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure changes: oestrogens in climacteric women.
Wren BG; Routledge DA
Med J Aust; 1981 Nov; 2(10):528-31. PubMed ID: 6275247
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
Aylward M; Holly F; Parker RJ
Curr Med Res Opin; 1974; 2(7):417-23. PubMed ID: 4375554
[No Abstract] [Full Text] [Related]
19. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
20. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
Wesel S; Bourguignon RP; Bosuma WB
Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
